Soc. Generale Call 95 DVA 20.12.2.../ DE000SQ497H4 /
6/17/2024 9:37:40 PM | Chg.+0.080 | Bid9:59:25 PM | Ask- | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.750EUR | +1.71% | 4.690 Bid Size: 2,000 |
- Ask Size: - |
DaVita Inc | 95.00 USD | 12/20/2024 | Call |
GlobeNewswire
4/26
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
11/17/2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
8/15/2023
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
3/21/2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
3/7/2022
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
2/10/2022
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
10/7/2021
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
10/1/2021
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors
GlobeNewswire
9/9/2021
ACTION BEHAVIOR CENTERS HIRES NEW GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
GlobeNewswire
9/9/2021
Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development